About Envoy Medical, Inc.
https://www.envoymedical.comEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
CEO
Brent T. Lucas
Compensation Summary
(Year 2023)
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
ARISTEIA CAPITAL LLC
Shares:1.06M
Value:$47.74K
SANDIA INVESTMENT MANAGEMENT LP
Shares:589.89K
Value:$26.54K
TORONTO DOMINION BANK
Shares:534.93K
Value:$24.07K
Summary
Showing Top 3 of 43
About Envoy Medical, Inc.
https://www.envoymedical.comEnvoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $42K ▼ | $5.55M ▲ | $-6.48M ▼ | -15.43K% ▼ | $-0.35 ▼ | $-5.93M ▼ |
| Q2-2025 | $78K ▲ | $4.91M ▼ | $-5.69M ▼ | -7.29K% ▲ | $-0.32 ▼ | $-4.98M ▼ |
| Q1-2025 | $46K ▲ | $4.93M ▲ | $-5M ▼ | -10.87K% ▲ | $-0.29 ▲ | $-4.44M ▼ |
| Q4-2024 | $42K ▼ | $4.41M ▼ | $-4.62M ▲ | -11K% ▼ | $-0.36 ▲ | $-4.19M ▲ |
| Q3-2024 | $56K | $4.84M | $-5.96M | -10.64K% | $-0.37 | $-5.65M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $3.56M ▼ | $8.18M ▼ | $15.71M ▼ | $-7.53M ▲ |
| Q2-2025 | $5.29M ▼ | $9.9M ▼ | $39.76M ▲ | $-29.86M ▼ |
| Q1-2025 | $5.31M ▼ | $10.38M ▼ | $34.61M ▲ | $-24.22M ▼ |
| Q4-2024 | $5.48M ▲ | $11.54M ▲ | $30.38M ▲ | $-18.84M ▼ |
| Q3-2024 | $4.42M | $9.4M | $27.93M | $-18.53M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-6.48M ▼ | $-4.33M ▲ | $0 ▲ | $2.6M ▼ | $-1.73M ▼ | $-4.33M ▲ |
| Q2-2025 | $-5.69M ▼ | $-4.46M ▼ | $-1K ▲ | $4.44M ▲ | $-25K ▲ | $-4.46M ▼ |
| Q1-2025 | $-5M ▲ | $-3.73M ▲ | $-6K ▼ | $3.55M ▼ | $-171K ▼ | $-3.73M ▲ |
| Q4-2024 | $-6.28M ▼ | $-4.39M ▼ | $534K ▲ | $4.91M ▼ | $1.06M ▼ | $-3.85M ▼ |
| Q3-2024 | $-5.96M | $-2.81M | $-615K | $6.1M | $2.68M | $-3.42M |
CEO
Brent T. Lucas
Compensation Summary
(Year 2023)
Ratings Snapshot
Rating : C
Price Target
Institutional Ownership
ARISTEIA CAPITAL LLC
Shares:1.06M
Value:$47.74K
SANDIA INVESTMENT MANAGEMENT LP
Shares:589.89K
Value:$26.54K
TORONTO DOMINION BANK
Shares:534.93K
Value:$24.07K
Summary
Showing Top 3 of 43